News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
StockStory.org on MSN1d
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.
CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found ...
CVS Health’s pharmacy benefit manager (PBM), CVS Caremark, joined forces with GoodRx to launch a prescription drug cost-saving program Wednesday. The Caremark Cost Saver gives CVS Caremark members the ...
CVS Caremark originally entered into a corporate integrity agreement in 2008, when it paid $36.7 million to resolve allegations from a CVS pharmacist that the company improperly switched patients ...
According to a study by CVS Health's pharmacy benefit manager, CVS Caremark, the average diabetic spends $467.24 out-of-pocket per year on their medication, including insulin, and 12% of them lay ...
CVS shares fell $2.32, or 7.4 percent, to close at $29.06 on the New York Stock Exchange while Caremark lost $1.06, or 2.2 percent, to finish at $48.17.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results